Efficacy of pranlukast for nasal symptoms and physical activity in asthma children with moderate/severe allergic rhinitis
Not Applicable
- Conditions
- allergic rhinitis
- Registration Number
- JPRN-UMIN000011408
- Lead Sponsor
- Mie National Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1) leukotriene receptor antagonists within 2 weeks before study entry 2) antihistamines within 2 weeks before study entry 3) nasal corticosteroids and/or nasal antihistamines within 2 weeks before study entry 4) systemic corticosteroids within 4 weeks before study entry 5) chronic diseases other than allergy 6) disability or dysfunction of physical activity 7) patients whom a study physician considers inappropriate for the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method symptom score of allergic rhinitis
- Secondary Outcome Measures
Name Time Method physical activity evaluated by using an accelerometer, Lifecorder EX